Details about Simon Wakeman

Access statistics for papers by Simon Wakeman.

Last updated 2022-11-06. Update your information in the RePEc Author Service.

Short-id: pwa760

Working Papers

2015

1. Measuring the innovative activity of New Zealand firms
   Working Papers, New Zealand Productivity Commission View citations (1)
2. What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry
   ESMT Research Working Papers, ESMT European School of Management and Technology
   See also Journal Article What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry, Research Policy, Elsevier (2016) View citations (36) (2016)

2013

3. Technology commercialization strategy in a dynamic context: Developing specialized complementary assets in entrepreneurial firms
   ESMT Research Working Papers, ESMT European School of Management and Technology View citations (1)

2012

4. How does obtaining intellectual property rights impact technology commercialization strategy for start-up innovators? Reconciling the effects on licensing vs. financing
   ESMT Research Working Papers, ESMT European School of Management and Technology View citations (1)

2010

5. Profiting from technological capabilities: Technology commercialization strategy in a dynamic context
   ESMT Research Working Papers, ESMT European School of Management and Technology View citations (2)

2008

6. Technology Commercialization Strategy in a Dynamic Context: Complementary Assets, Hybrid Contracts, and Experiential Learing
   DRUID Working Papers, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies

Journal Articles

2016

1. What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry
   Research Policy, 2016, 45, (5), 1091-1102 View citations (36)
   See also Working Paper What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry, ESMT Research Working Papers (2015) (2015)